RTI Biologics is a new growth Biomed
ARTICLE AND GRAPHS
While screening on Barchart for small cap stocks having great price momentum I came across RTI Biologiics (RTIX) an undiscovered stock that is beginning to be put on analysts' watch lists. The bio-medical sector is starting to move and the product line of this stock is wanted and necessary. Just look at the 11 new highs and 14.24% price appreciation this stock received even in a soft market.
Chart provided with permission of Barchart
Barchart technical indicators:
1 - 96% Barchart technical buy signals
2 - Trend Spotter buy signal
3 - Above its 20, 50 and 100 day moving- averages
4 - 11 new highs and up 14.24% in the last month
5 - Relative Strength Index 60.27% and rising
6 - Barchart computes a support level at 3.24
7 - Traded recently at 3.43 which is above its 50 day moving average of 3.05
Summary: RTI Biologics (RTIX) is in that sweet spot I like for speculative growth stocks. It has press and is being followed by major stock information sites like Value Line and Motley Fool and has drawn the attention of Wall Street analyst but as yet has not been added to any of their model portfolios. I couldn't pass up these aggressive double digit earnings projects and have added it to both my own account and the accounts of my managed money portfolios.
I think the cultured bone and tissue industry will be a big medical growth area and this company has proven products. Because of its low price and high P/E ration this stock should be acquired only for speculative portfolios but deserves a place on the watch lists of all growth oriented investors.
Jim Van Meerten is a Marketocracy Master